Vision loss has long been treated as a one-way street, a devastating endpoint rather than a problem the brain might quietly work to solve. A wave of research is now overturning that assumption, ...

Scientists in Canada have developed a new technique that may one day help restore some sight to patients with inherited vision impairment. The regenerative therapy works by expressing genes that ...

Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...

The case marks the first time sight has been partially restored using optogenetics, a type of biological research aimed at controlling nerve cells via light. Jackson Ryan was CNET's science editor, ...

For some degenerative vision disorders, the therapies available don’t restore sight, they mainly slow its decline. To realize this benefit, a patient must receive an eye injection as frequently as ...

Please provide your email address to receive an email when new articles are posted on . Advanced Research Projects Agency for Health has launched a program to restore vision through whole eye ...

A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind ...

Elon Musk recently pronounced that the next Neuralink project will be a “Blindsight” cortical implant to restore vision: “Resolution will be low at first, like early Nintendo graphics, but ultimately ...

Elon Musk said Neuralink could potentially restore full body functionality by bridging damaged spinal cords through ...

Imagine slowly losing the center of your vision, like a camera lens fading to fog. That's what happens with geographic atrophy, a severe form of age-related macular degeneration (AMD). It's the ...

The Science Eye is an intriguing piece of technology. Developed by Science Corp., the bionic eye seeks to restore vision in patients suffering from a variety of vision-based diseases. But, it also ...

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients.